Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002048690-25-000001
Filing Date
2025-01-29
Accepted
2025-01-29 17:08:46
Documents
1
Effectiveness Date
2025-01-29
Items
Item 06c:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13500
  Complete submission text file 0002048690-25-000001.txt   14794
Mailing Address C/O OAKTREE CAPITAL MANAGEMENT, L.P. 333 S. GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071
Business Address C/O OAKTREE CAPITAL MANAGEMENT, L.P. 333 S. GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071 213-830-6300
Oaktree Life Sciences Income Fund (Parallel), L.P. (Filer) CIK: 0002048690 (see all company filings)

IRS No.: 981824486 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-536747 | Film No.: 25570261